Details for 2016819718

Up to date per 04.04.2026

Actions

Title / Product Name

BEHANDLUNG VON LUNGENKREBS MIT EINER KOMBINATION AUS EINEM ANTI-PD-1-ANTIKÖRPER UND EINEM ANTI-CTLA-4-ANTIKÖRPER

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016819718

EP Publication Number

3377534

E-Number

1804126

Language

PCT Number

US16062884

Publication Date

26.09.2018 A

18.06.2025 B1

Registration Date

18.06.2025

AT Publication Date

15.07.2025

Application Date

18.11.2016

Registration Number

Priorities

18.11.2015

201562257139 P

03.06.2016

201662345314 P

IPC

C07K 16/28 20060101AFI20250123BHEP

Maximum Duration of Protection

18.11.2036

Owner

Bristol-Myers Squibb CompanyRoute 206 and Province Line Road Princeton, NJ 08543US

Representative

No representatives present

Inventor

FAITH, Nathan E.Rt. 206&Province Line Road Princeton, New Jersey 08543US

Information about Fees